Those neon packets and tiny bottles of so-called "gas-station heroin" could be on their way out in New York. State lawmakers this spring signed off on a measure to block the sale of concentrated or synthetic kratom products with high levels of 7-hydroxymitragynine, better known as 7-OH, and the bill is now headed to Gov. Kathy Hochul's desk. The target is a fast-growing lineup of tablets, gummies and drink shots that critics say look like candy but hit like powerful opioids. If Hochul signs the bill, the rules would reshape how kratom is sold across the state, from smoke shops to corner stores.
What the bill bans
Under the legislation, a "7-hydroxymitragynine product" is any finished product that contains 7-OH at more than two percent of total alkaloids or more than 1 milligram per serving, and those products could not be sold anywhere in New York. The bill also authorizes regulators to bar synthesized or semi-synthetic kratom materials, combustible or injectable versions, and products designed or packaged to appeal to people under 21. Businesses that violate the rules would face civil penalties, with those fines routed into the state's Drug Treatment and Public Education Fund, and the measure is set to take effect 90 days after it becomes law, according to the bill page from the New York State Senate.
How lawmakers described the threat
Supporters cast the move as a narrow consumer-safety response focused on unregulated concentrates, not on traditional kratom leaf. During debate, lawmakers said the concentrated 7-OH products were emerging as a troubling new entry point in the opioid crisis, with physicians warning about their potency. "We want to save as many people from this evil substance," Assemblyman Phil Steck said as the measure advanced through the Legislature, according to Spectrum News.
Why public-health officials are alarmed
Federal and state health agencies say highly concentrated 7-OH can trigger opioid-like respiratory depression, severe dependence and overdose, especially at doses far above the trace levels that naturally occur in kratom leaf. The U.S. Food and Drug Administration has called 7-OH "an emerging public health threat," and New York's Office of Addiction Services and Supports says the state began specifically tracking 7-OH last year as kratom-related calls to poison centers increased. The FDA provides background and resources for clinicians and consumers.
What enforcement will look like
Once the law is in place, businesses that knowingly sell banned 7-OH products would be subject to civil penalties, with the Legislature directing that money to treatment and public-education efforts. The Senate version of the bill spells out the fine structure and the 90-day implementation period, which means retailers would have to pull covered products from their shelves on that timeline if Hochul signs it. Those details appear in the text posted by the New York State Senate.
Part of a national wave of restrictions
New York's move is landing in the middle of a wider national clampdown. Across the country, city councils and state lawmakers have been rolling out proposals to restrict synthetic 7-OH or tighten rules on kratom sales, creating a patchwork of bans and regulations. Local reporting describes debates from Kansas City to communities in California over new ordinances and statewide measures, while New York last year adopted earlier consumer protections that raised the legal age for purchase and required ingredient labels on kratom products. KSHB has covered efforts in the Midwest, and the governor's office has outlined New York's prior steps.
The bill now sits with Hochul. If she signs it, the law would take effect 90 days later, and regulators would begin enforcement on the schedule set out in the statute. New Yorkers who have questions about kratom, or anyone seeking help, can find information and a 24/7 HOPEline through the state's Office of Addiction Services and Supports at OASAS.
